Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-29 Purchase | 2022-05-03 5:49 pm | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 2,118,644 | $2.36 | $5,000,000 | 4,295,055 (Indirect) | View |
| 2020-12-30 Purchase | 2021-01-04 6:02 pm | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director | 1,347,709 | $3.71 | $5,000,000 | 4,450,638 (Indirect) | View |
| 2020-10-20 Purchase | 2020-10-20 5:00 pm | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 200,000 | $15 | $3,000,000 | 862,444 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 7:03 pm | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 225,000 | $18 | $4,050,000 | 4,959,769 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:57 pm | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect) | View |
| 2018-05-15 Sale | 2018-05-17 5:11 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 44,000 | $57.99 | $2,551,440 | 645,643 (Indirect Direct) | View |
| 2018-05-07 Sale | 2018-05-09 5:15 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 121,362 | $50.39 | $6,115,873 | 96,359 (Indirect Direct) | View |
| 2018-04-30 Sale | 2018-05-02 6:00 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,566 | $50.29 | $1,537,138 | 106,018 (Indirect Direct) | View |
| 2018-04-26 Sale | 2018-04-30 8:57 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 222,258 | $50.11 | $11,136,437 | 100,780 (Indirect) | View |
| 2018-04-24 Sale | 2018-04-26 5:01 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 22,841 | $50.99 | $1,164,655 | 115,645 (Indirect) | View |
| 2018-04-20 Sale | 2018-04-24 7:42 pm | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 101,994 | $50.68 | $5,168,901 | 812,614 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-23 Option Award | 2022-06-27 4:14 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:33 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-07-01(A) Option Award | 2021-09-20 8:13 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-08-25 Other | 2021-08-27 5:49 pm | N/A N/A | Gritstone bio Inc. | GRTS | Woiwode Thomas Director | 458,152 | $0 | 3,574,489 (Indirect) | View |
| 2021-07-01 Option Award | 2021-07-06 6:01 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 9:54 pm | N/A N/A | Millendo Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 2,176,411 | $0 | 7,377 (Indirect) | View |
| 2021-06-17 Option Award | 2021-06-17 5:14 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-11 Other | 2021-06-15 4:43 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 506,307 | $0 | 1,391,305 (Indirect) | View |
| 2021-05-27 Option Award | 2021-05-28 6:06 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-14 8:05 pm | N/A 2031-05-11 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 506,310 | $0 | 1,389,085 (Indirect) | View |
| 2020-12-14 Other | 2020-12-16 5:10 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 12,783 | $0 | 31,605 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 3,092,339 | $0 | 862,444 (Indirect) | View |
| 2020-10-15 Ownership | 2020-10-15 5:17 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 0 | $0 | 3,092,339 (Indirect) | View |
| 2020-06-23 Option Award | 2020-06-25 5:45 pm | N/A 2030-06-22 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-22 5:40 pm | N/A 2030-06-18 | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 4,734,769 | $0 | 4,959,769 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 4,734,769 | $0 | 933,352 (Indirect) | View |
| 2020-02-27 Option Award | 2020-03-02 6:01 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 33,836 | $0 | 33,836 (Direct) | View |
| 2020-02-27 Ownership | 2020-02-27 8:07 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Woiwode Thomas 10% Owner | 0 | $0 | 4,734,769 (Direct) | View |
| 2020-02-27 Ownership | 2020-02-27 7:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 0 | $0 | 4,734,769 (Indirect) | View |
| 2019-07-31 Option Award | 2019-08-02 4:25 pm | N/A 2029-07-30 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-20 4:17 pm | N/A 2029-06-19 | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 8,570 | $0 | 8,570 (Direct) | View |
| 2018-10-02 Conversion | 2018-10-02 5:29 pm | N/A N/A | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 6,205,858 | $0 | 3,102,929 (Indirect) | View |
| 2018-09-27 Ownership | 2018-09-27 5:26 pm | N/A N/A | Gritstone Oncology Inc. | GRTS | Woiwode Thomas Director 10% Owner | 0 | $0 | 3,102,929 (Indirect) | View |
| 2018-06-15 Option Award | 2018-06-15 9:39 pm | N/A 2028-06-15 | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2018-05-31 Option Award | 2018-06-15 4:27 pm | N/A 2028-05-30 | Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2018-04-20 Other | 2018-04-24 7:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Woiwode Thomas Director | 595,241 | $0 | 812,614 (Indirect) | View |